Key Record Dates Identifier: NCT04467515
Brief Title: A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer

First Submitted : June 10, 2020
First Submitted that Met QC Criteria : July 7, 2020
First Posted : July 13, 2020

Last Update Submitted that Met QC Criteria : January 26, 2021
Last Update Posted : January 27, 2021